nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGIS—Nicotinate metabolism—NMNAT1—age related macular degeneration	0.396	0.396	CbGpPWpGaD
Phenylbutazone—PTGS2—Nicotinate metabolism—NMNAT1—age related macular degeneration	0.0967	0.0967	CbGpPWpGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT1—age related macular degeneration	0.0758	0.0758	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0292	0.0292	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0223	0.0223	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0186	0.0186	CbGpPWpGaD
Phenylbutazone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT1—age related macular degeneration	0.0185	0.0185	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CRP—age related macular degeneration	0.0148	0.0148	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.0147	0.0147	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0133	0.0133	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CRP—age related macular degeneration	0.0118	0.0118	CbGpPWpGaD
Phenylbutazone—PTGS2—S1P1 pathway—KDR—age related macular degeneration	0.0113	0.0113	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0101	0.0101	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NMNAT1—age related macular degeneration	0.00897	0.00897	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—RDH8—age related macular degeneration	0.00897	0.00897	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00845	0.00845	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—RPE65—age related macular degeneration	0.00784	0.00784	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00756	0.00756	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—NMNAT1—age related macular degeneration	0.00751	0.00751	CbGpPWpGaD
Phenylbutazone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—age related macular degeneration	0.00714	0.00714	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00674	0.00674	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00674	0.00674	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ELOVL4—age related macular degeneration	0.00657	0.00657	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00644	0.00644	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ABCA4—age related macular degeneration	0.00632	0.00632	CbGpPWpGaD
Phenylbutazone—PTGS2—S1P1 pathway—VEGFA—age related macular degeneration	0.00622	0.00622	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00608	0.00608	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00587	0.00587	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00577	0.00577	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—RHO—age related macular degeneration	0.0055	0.0055	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—SLC16A8—age related macular degeneration	0.00529	0.00529	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00514	0.00514	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00514	0.00514	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00482	0.00482	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00453	0.00453	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00435	0.00435	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00429	0.00429	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00429	0.00429	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00378	0.00378	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.0036	0.0036	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00358	0.00358	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00353	0.00353	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00345	0.00345	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CST3—age related macular degeneration	0.00344	0.00344	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00339	0.00339	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00333	0.00333	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00311	0.00311	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TGFBR1—age related macular degeneration	0.00309	0.00309	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00307	0.00307	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00284	0.00284	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—LIPC—age related macular degeneration	0.00271	0.00271	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TLR4—age related macular degeneration	0.00262	0.00262	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CETP—age related macular degeneration	0.00261	0.00261	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00254	0.00254	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00238	0.00238	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NMNAT1—age related macular degeneration	0.00231	0.00231	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CCL2—age related macular degeneration	0.00225	0.00225	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NMNAT1—age related macular degeneration	0.00219	0.00219	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RDH8—age related macular degeneration	0.00219	0.00219	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00212	0.00212	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ELOVL4—age related macular degeneration	0.00202	0.00202	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RPE65—age related macular degeneration	0.00191	0.00191	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00187	0.00187	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NMNAT1—age related macular degeneration	0.00183	0.00183	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.0018	0.0018	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—APOE—age related macular degeneration	0.00165	0.00165	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC16A8—age related macular degeneration	0.00163	0.00163	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ELOVL4—age related macular degeneration	0.0016	0.0016	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CD36—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ABCA4—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00143	0.00143	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—APOE—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RHO—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC16A8—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000983	0.000983	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000982	0.000982	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000957	0.000957	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000948	0.000948	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000861	0.000861	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000855	0.000855	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CST3—age related macular degeneration	0.000839	0.000839	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LIPC—age related macular degeneration	0.000833	0.000833	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CETP—age related macular degeneration	0.000803	0.000803	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000801	0.000801	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000759	0.000759	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFBR1—age related macular degeneration	0.000753	0.000753	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.0007	0.0007	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LIPC—age related macular degeneration	0.000661	0.000661	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CETP—age related macular degeneration	0.000638	0.000638	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00057	0.00057	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000564	0.000564	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000503	0.000503	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CD36—age related macular degeneration	0.000483	0.000483	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000438	0.000438	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOE—age related macular degeneration	0.000426	0.000426	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000422	0.000422	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOE—age related macular degeneration	0.000404	0.000404	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CD36—age related macular degeneration	0.000383	0.000383	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOE—age related macular degeneration	0.000338	0.000338	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000289	0.000289	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000279	0.000279	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000254	0.000254	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000224	0.000224	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CD36—age related macular degeneration	0.000167	0.000167	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000148	0.000148	CbGpPWpGaD
